Hyderabad-based dialysis care provider NephroPlus has acquired DaVita Care India, the Indian arm of the US-based DaVita Inc, for an undisclosed amount.
As part of the deal, NephroPlus will acquire all the 22 DaVita Care centres, serving more than 1,700 dialysis patients, across the country. With the acquisition, NephroPlus will strengthen its presence in India, expanding to 176 centres in 97 cities, across 18 states in the country.
DaVita Care (India) is a network of dialysis and kidney care centres that provide care for acute and end-stage renal disease patients in India. It offers dialysis services, including in-centre and home hemodialysis, peritoneal dialysis, and AV Fistula and AV graft procedures, and allied services that include psychological counselling and diet and nutrition advice.
NephroPlus was founded by Vikram Vuppala, Kamal D Shah and Sandeep Gudibanda in 2009. The healthcare company provides quality dialysis service to its patients at affordable prices, enabling them to lead unhindered normal lives.
The company serves more than 12,000 patients through a network of over 150 clinics, across 18 states.
NephroPlus is further looking to expand to the South East Asian market through acquisitions and is in the process of raising ₹150 crore, from existing and new investors.
Talking about the acquisition, Kamal Shah, Co-Founder, NephroPlus, said, “We are excited to bring our proactive approach to clinical outcomes, no-comprise clinical quality and safety and guest-centric care to many more people on dialysis. We will be able to touch many more lives through this acquisition and showcase our core value of ‘Guest care comes first’ to more people on dialysis.”
NephroPlus posted ₹150 crores in revenues in FY18, compared to ₹93 crore in FY17. The company is looking to continue its growth and expects to clock ₹200 crore in revenues in FY19.
In August 2018, the company raised ₹100 crore in a series D funding round led by SeaLink Capital Partners, along with participation from International Finance Corporation.
According to an IBEF report, the Indian healthcare industry is expected to touch $280 billion by 2022, from $100 billion currently.